On June 19 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On June 18 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration will hold a meeting on implementation of certain provisions of the Food and Drug Administration Safety and Innovation Act, including standards for admission of imported drugs and commercial drug importers. The July 12 meeting in Silver Spring, Md., will include a general overview on FDASIA's Title VII supply chain integrity protections. FDA will also ask for input on the types of information that importers should be required to provide as a condition of admission, as well as registration requirements for commercial drug importers and good importer practices.
On June 14 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On June 13 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for June 12 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
On June 12 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On June 11 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration may refuse imports of drug products manufactured at two RPG Life Sciences facilities in India, the agency said in a May 28 warning letter. An FDA inspection at the company’s facility in Navi Mumbai allegedly found current good manufacturing practice violations for active pharmaceutical ingredients. An inspection of RPG’s facility in Ankleshwar found violations of CGMP for finished pharmaceuticals, FDA said.
The Food and Drug Administration issued the June Interstate Certified Shellfish Shippers List (ICSSL). The ICSSL is published monthly for the information and use by food control officers, the seafood industry and other interested persons. The shippers listed have been certified by regulatory authorities in the U.S., Canada, Chile, Korea, Mexico and New Zealand under the uniform sanitation requirements of the National Shellfish Program.